Skip to main content

VKTX

Stock
Health Care
Biotechnology

Performance overview

VKTX Price
Price Chart

Forward-looking statistics

Beta
1.16
Risk
85.24%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

novel therapeutics for metabolic and endocrine disorders.

Company info

SectorHealth Care
IndustryBiotechnology
Employees22
Market cap$6.2B

Fundamentals

Enterprise value$2.1B
Revenue$0.0
Revenue per employee—
Profit margin0.00%
Debt to equity0.12

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$1.16
Dividend per share—
Revenue per share—
Avg trading volume (30 day)$107M
Avg trading volume (10 day)$139M
Put-call ratio—

Macro factor sensitivity

Growth+6.0
Credit+4.3
Liquidity-1.5
Inflation+1.2
Commodities+0.5
Interest Rates-1.7

Valuation

Dividend yield0.00%
PEG Ratio-18.67
Price to sales—
P/E Ratio-18.67
Enterprise Value to Revenue—
Price to book3.74

Upcoming events

Next earnings dayApril 24, 2025
Next dividend day—
Ex. dividend day—

News

Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts

Viking Therapeutics, Inc. (VKTX) reached $31.29 at the closing of the latest trading day, reflecting a +2.93% change compared to its last close.

Zacks Investment Research (July 10, 2025)
What's Going On With Viking Therapeutics Stock On Wednesday?

Viking Therapeutics, Inc. VKTX on Wednesday initiated the VANQUISH Phase 3 clinical program for VK2735, the company's dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.

Benzinga (June 25, 2025)
Pharma companies need to beef up M&A right now, says Mizuho's Jared Holz

Jared Holxz, Mizuho, joins 'Fast Money' to talk competition in the obesity drug space.

CNBC Television (June 23, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free